REPORTS

Let’s Pullulate and Expand Your Business

Molecular Diagnostics Market - Global Professional Analysis and Forecast to 2026

Oct 17, 2019  |  161 PAGES  |  REPORT CODE: CMM214301
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Molecular Diagnostics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 15.2% during the forecast period.

This report presents the market size and development trends by detailing the Molecular Diagnostics market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Molecular Diagnostics market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Molecular Diagnostics industry and will help you to build a panoramic view of the industrial development.

Molecular Diagnostics Market, By Type:

  • PCR

  • DNA Sequencing

  • FISH

  • DNA Blotting

  • SNP

  • LCR

  • Gene Chip

Molecular Diagnostics Market, By Application:

  • Hospital

  • Laboratory

  • Others

Some of the leading players are as follows:

  • BGI–Shenzhen

  • Gen-Probe

  • Guangzhou Kingmed Diagnostics Center Co. Ltd.

  • Biomerieux

  • Thermo Fisher

  • Hongshitech

  • Illumina

  • Bayer AG

  • Bioneer

  • Cepheid

  • Bio-Rad Laboratories

  • BD

  • Siemens

  • Hologic, Inc. (Gen probe)

  • OriGene Technologies

  • Danaher

  • GE

  • Roche Diagnostics

  • Siemens Healthcare GmbH

  • Novartis AG

  • Abbott

  • Daan Gene

  • Qiagen N.V.

  • bioMerieux SA

  • Dako

  • ADICON Clinical Laboratories (Privately held)

  • Sysmex Corporation

  • Kindstar Global (Privately held)

  • Johnson & Johnson

  • Alere, Inc.

  • Zhejiang Di’an Diagnostics Technology Co., Ltd.

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Molecular Diagnostics Market: Technology Type Analysis

  • 4.1 Molecular Diagnostics Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Molecular Diagnostics Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 PCR

    • 4.3.2 DNA Sequencing

    • 4.3.3 FISH

    • 4.3.4 DNA Blotting

    • 4.3.5 SNP

    • 4.3.6 LCR

    • 4.3.7 Gene Chip

5 Molecular Diagnostics Market: Product Analysis

  • 5.1 Molecular Diagnostics Product Market Share Analysis, 2018 & 2026

  • 5.2 Molecular Diagnostics Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Molecular Diagnostics Market: Application Analysis

  • 6.1 Molecular Diagnostics Application Market Share Analysis, 2018 & 2026

  • 6.2 Molecular Diagnostics Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospital

    • 6.3.2 Laboratory

    • 6.3.3 Others

7 Molecular Diagnostics Market: Regional Analysis

  • 7.1 Molecular Diagnostics Regional Market Share Analysis, 2018 & 2026

  • 7.2 Molecular Diagnostics Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 BGI–Shenzhen

    • 9.1.1 BGI–Shenzhen Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Gen-Probe

    • 9.2.1 Gen-Probe Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Guangzhou Kingmed Diagnostics Center Co. Ltd.

    • 9.3.1 Guangzhou Kingmed Diagnostics Center Co. Ltd. Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Biomerieux

    • 9.4.1 Biomerieux Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Thermo Fisher

    • 9.5.1 Thermo Fisher Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Hongshitech

    • 9.6.1 Hongshitech Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Illumina

    • 9.7.1 Illumina Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Bayer AG

    • 9.8.1 Bayer AG Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Bioneer

    • 9.9.1 Bioneer Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Cepheid

    • 9.10.1 Cepheid Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Bio-Rad Laboratories

    • 9.11.1 Bio-Rad Laboratories Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 BD

    • 9.12.1 BD Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Siemens

    • 9.13.1 Siemens Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Hologic, Inc. (Gen probe)

    • 9.14.1 Hologic, Inc. (Gen probe) Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 OriGene Technologies

    • 9.15.1 OriGene Technologies Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 Danaher

    • 9.16.1 Danaher Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 GE

    • 9.17.1 GE Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

  • 9.18 Roche Diagnostics

    • 9.18.1 Roche Diagnostics Company overview

    • 9.18.2 Financial performance

    • 9.18.3 Product benchmarking

    • 9.18.4 Strategic initiatives

    • 9.18.5 SWOT analysis

  • 9.19 Siemens Healthcare GmbH

    • 9.19.1 Siemens Healthcare GmbH Company overview

    • 9.19.2 Financial performance

    • 9.19.3 Product benchmarking

    • 9.19.4 Strategic initiatives

    • 9.19.5 SWOT analysis

  • 9.20 Novartis AG

    • 9.20.1 Novartis AG Company overview

    • 9.20.2 Financial performance

    • 9.20.3 Product benchmarking

    • 9.20.4 Strategic initiatives

    • 9.20.5 SWOT analysis

  • 9.21 Abbott

    • 9.21.1 Abbott Company overview

    • 9.21.2 Financial performance

    • 9.21.3 Product benchmarking

    • 9.21.4 Strategic initiatives

    • 9.21.5 SWOT analysis

  • 9.22 Daan Gene

    • 9.22.1 Daan Gene Company overview

    • 9.22.2 Financial performance

    • 9.22.3 Product benchmarking

    • 9.22.4 Strategic initiatives

    • 9.22.5 SWOT analysis

  • 9.23 Qiagen N.V.

    • 9.23.1 Qiagen N.V. Company overview

    • 9.23.2 Financial performance

    • 9.23.3 Product benchmarking

    • 9.23.4 Strategic initiatives

    • 9.23.5 SWOT analysis

  • 9.24 bioMerieux SA

    • 9.24.1 bioMerieux SA Company overview

    • 9.24.2 Financial performance

    • 9.24.3 Product benchmarking

    • 9.24.4 Strategic initiatives

    • 9.24.5 SWOT analysis

  • 9.25 Dako

    • 9.25.1 Dako Company overview

    • 9.25.2 Financial performance

    • 9.25.3 Product benchmarking

    • 9.25.4 Strategic initiatives

    • 9.25.5 SWOT analysis

  • 9.26 ADICON Clinical Laboratories (Privately held)

    • 9.26.1 ADICON Clinical Laboratories (Privately held) Company overview

    • 9.26.2 Financial performance

    • 9.26.3 Product benchmarking

    • 9.26.4 Strategic initiatives

    • 9.26.5 SWOT analysis

  • 9.27 Sysmex Corporation

    • 9.27.1 Sysmex Corporation Company overview

    • 9.27.2 Financial performance

    • 9.27.3 Product benchmarking

    • 9.27.4 Strategic initiatives

    • 9.27.5 SWOT analysis

  • 9.28 Kindstar Global (Privately held)

    • 9.28.1 Kindstar Global (Privately held) Company overview

    • 9.28.2 Financial performance

    • 9.28.3 Product benchmarking

    • 9.28.4 Strategic initiatives

    • 9.28.5 SWOT analysis

  • 9.29 Johnson & Johnson

    • 9.29.1 Johnson & Johnson Company overview

    • 9.29.2 Financial performance

    • 9.29.3 Product benchmarking

    • 9.29.4 Strategic initiatives

    • 9.29.5 SWOT analysis

  • 9.30 Alere, Inc.

    • 9.30.1 Alere, Inc. Company overview

    • 9.30.2 Financial performance

    • 9.30.3 Product benchmarking

    • 9.30.4 Strategic initiatives

    • 9.30.5 SWOT analysis

  • 9.31 Zhejiang Di’an Diagnostics Technology Co., Ltd.

    • 9.31.1 Zhejiang Di’an Diagnostics Technology Co., Ltd. Company overview

    • 9.31.2 Financial performance

    • 9.31.3 Product benchmarking

    • 9.31.4 Strategic initiatives

    • 9.31.5 SWOT analysis

 

The List of Tables and Figures (Totals 60 Figures and 160 Tables)

  • Figure PCR Molecular Diagnostics market, 2015 - 2026 (USD Million)

  • Figure DNA Sequencing Molecular Diagnostics market, 2015 - 2026 (USD Million)

  • Figure FISH Molecular Diagnostics market, 2015 - 2026 (USD Million)

  • Figure DNA Blotting Molecular Diagnostics market, 2015 - 2026 (USD Million)

  • Figure SNP Molecular Diagnostics market, 2015 - 2026 (USD Million)

  • Figure LCR Molecular Diagnostics market, 2015 - 2026 (USD Million)

  • Figure Gene Chip Molecular Diagnostics market, 2015 - 2026 (USD Million)

  • Figure Hospital market, 2015 - 2026 (USD Million)

  • Figure Laboratory market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Molecular Diagnostics market, by country, 2015 - 2026 (USD Million)

  • Table North America Molecular Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table North America Molecular Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table North America Molecular Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Molecular Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Molecular Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Molecular Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Molecular Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Canada Molecular Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Canada Molecular Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Europe Molecular Diagnostics market, by country, 2015 - 2026 (USD Million)

  • Table Europe Molecular Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Europe Molecular Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Europe Molecular Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Molecular Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Molecular Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Molecular Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Molecular Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Germany Molecular Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Germany Molecular Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Molecular Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table France Molecular Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table France Molecular Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Molecular Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Italy Molecular Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Italy Molecular Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Molecular Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Spain Molecular Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Spain Molecular Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Molecular Diagnostics market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Molecular Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Molecular Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Molecular Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Molecular Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table China Molecular Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table China Molecular Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Molecular Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Japan Molecular Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Japan Molecular Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Molecular Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table India Molecular Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table India Molecular Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Molecular Diagnostics market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Molecular Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Molecular Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Molecular Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Molecular Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Molecular Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Molecular Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Molecular Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Molecular Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Molecular Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Molecular Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Molecular Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Molecular Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table MEA Molecular Diagnostics market, by country, 2015 - 2026 (USD Million)

  • Table MEA Molecular Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table MEA Molecular Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table MEA Molecular Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Molecular Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Molecular Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Molecular Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Molecular Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Molecular Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Molecular Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table BGI–Shenzhen Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Gen-Probe Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Guangzhou Kingmed Diagnostics Center Co. Ltd. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Biomerieux Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Thermo Fisher Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Hongshitech Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Illumina Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bioneer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cepheid Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bio-Rad Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table BD Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Siemens Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Hologic, Inc. (Gen probe) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table OriGene Technologies Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Danaher Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GE Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Roche Diagnostics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Siemens Healthcare GmbH Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbott Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Daan Gene Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Qiagen N.V. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table bioMerieux SA Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Dako Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table ADICON Clinical Laboratories (Privately held) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sysmex Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Kindstar Global (Privately held) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Alere, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Zhejiang Di’an Diagnostics Technology Co., Ltd. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top